ADR adherium limited

20.0%

0.6¢

All is distilled as we report revenue in the Appendix 4CCan't...

First 3 Last

Share
Profile

Follow
Brewstex

2,401 Posts.

849

10/04/23

15:04

Post #: 67204144
Share

Originally posted by CM662: ↑

I asked ADR these question on their investor forum about generics, my take on their answer in short with questions, full answer below

You say you have 79% and 91% of the top 20 branded inhalers.
Within that segment how many of the top 20 branded inhalers have a generic equivalent and are ADRs device compatible with those. ANSWER ADR dont know.

Of the top 20 generic inhalers measured in the same way ar the 79 and 91% mentioned here what % coverage does ADR have. ANSWER ADR dont know
.
When will you be sharing data on the success of the devIces with physiological measures in terms of number of customers,sales patient uptake of these newer devices and how they are helping you achieve the goals you set youself in the updated investor presentation in August 2022 ANSWER, we have not told you when you asked before and we are not changingor tack or keeping investors in the dark with genric statements and no details on revenue.

Answer Which I take as " I dont want to answer you question or we dont know or we dont understand or see generics as a threat ? really?"

We believe a key for business success is focus. Such is our emphasis on the U.S. Top 20 branded inhaler medications. With 51 million patients diagnosed with asthma and COPD in the U.S. and 8.5 million of those considered severe and difficult to treat, there is a large, attractive market to service with branded inhalers. Generics will be evaluated on an on-going basis as well as the strategy and approach to service that market if the ROI is deemed appropriate.We are selling and deploying our entire Hailie product portfolio which means both sensors with physiological parameters and the prior generation with adherence parameters. The sensors may be deployed on both maintenance inhalers and rescue inhalers. In the U.S. sensor deployment also considers remote patient monitoring reimbursement models as all Hailie sensor enable reimbursement for Medicare’s remote therapeutic monitoring and the new, next generation sensors enable Medicare’s remote physiological monitoring. All is distilled as we report revenue in the Appendix 4C and will provide further updates on our progress towards these goals.

Expand

All is distilled as we report revenue in the Appendix 4C

Can't believe I'm saying it but after that comment I'm kind of keen to see ADR's revenue in the next Quarterly. All is revealed hey. I'll believe it when I see it.

.

ADR Price at posting: 0.4¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

AAU

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Trump just dropped a 200% tariff bomb. Here's how to cash in

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

VMM

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

LIS

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

ILU

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

CWX

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

AII

Inside the depths of Panasqueira: A legacy carved in rock

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.6¢		Change 0.001(20.0%)		Mkt cap ! $8.321M

Open	High	Low	Value	Volume
0.6¢	0.6¢	0.6¢	$2.401K	400.1K

Buyers (Bids)

No.	Vol.	Price($)
3	2150000	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	410143	3

View Market Depth

No.	Vol.	Price($)
3	2150000	0.005
22	10553874	0.004
10	5843588	0.003
4	10050000	0.002
5	25600000	0.001

Price($)	Vol.	No.
0.006	30143	2
0.007	287000	2
0.008	3125000	2
0.009	807118	2
0.010	150000	1

Last trade - 15.10pm 11/07/2025 (20 minute delay)

ADR (ASX) Chart

All is distilled as we report revenue in the Appendix 4CCan't...

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Trump just dropped a 200% tariff bomb. Here's how to cash in

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Inside the depths of Panasqueira: A legacy carved in rock

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

All is distilled as we report revenue in the Appendix 4CCan't...

Top Stories

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Trump just dropped a 200% tariff bomb. Here's how to cash in

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Inside the depths of Panasqueira: A legacy carved in rock

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News